Bayer and its Monsanto subsidiary have faced over 120,000 Roundup lawsuits, with approximately $10 billion already paid to resolve allegations that the weed killer causes cancer. Despite these payouts, the company faces approximately 67,000 pending Roundup lawsuits and has set aside an additional $5.9 billion for future legal expenses and potential Roundup settlements. In response to the mounting litigation, Bayer is making another push to resolve the lawsuits, including a possible Chapter 11 bankruptcy filing for its Monsanto subsidiary.
This potential bankruptcy move by Bayer comes after the company’s previous petitions to the U.S. Supreme Court were rejected, leaving the company searching for alternative solutions. Additionally, while Bayer announced plans in 2021 to reformulate Roundup by removing glyphosate from consumer versions, this action may not shield the company from lawsuits filed by former users who allegedly developed cancer from exposure to the product.
Bayer Initiates Roundup Settlement Talks in Missouri
Bayer continues pursuing legal avenues to limit liability for Roundup cancer claims, including a petition to the Supreme Court arguing that federal law preempts state failure-to-warn claims. The company has announced plans to try to resolve some of its Roundup lawsuits in Missouri, where many claims await trial in St. Louis County. The financial stakes are immense for Bayer – the average payout for Roundup settlements has been approximately $160,000 per plaintiff, though actual amounts vary considerably based on illness severity, medical expenses, and evidence strength.
Bayer Prepares Monsanto Bankruptcy as Contingency Plan
As settlement discussions continue, Bayer has simultaneously prepared a Chapter 11 bankruptcy filing for its Monsanto unit as a strategic contingency plan in case settlement talks fall through. If implemented, this bankruptcy strategy would effectively pause all pending Roundup lawsuits against Monsanto and channel both current and future claims through bankruptcy court. Such a maneuver provides Bayer with a potential path to consolidate its massive litigation exposure and establish a trust to handle all claims while potentially limiting the total payout amount.
Unlike other major corporations facing mass tort litigation, Bayer’s approach differs from the controversial “Texas Two-Step” tactic employed by Johnson & Johnson to deal with talcum powder cancer claims and 3M for combat arms earplug lawsuits. Those companies created new subsidiaries specifically designed to absorb liability before declaring bankruptcy. In contrast, Monsanto existed independently as Roundup’s manufacturer long before Bayer’s $63 billion acquisition in 2018.
This distinction could prove legally significant. Legal analysts note that because Monsanto has a direct connection to the product and associated health claims, bankruptcy courts might be more receptive to this filing compared to artificially created liability shields like Johnson & Johnson’s Red River Talc subsidiary. Nevertheless, such maneuvers face increasing judicial scrutiny, with recent rulings emphasizing that bad-faith filings or a lack of genuine financial distress could justify dismissal. For Bayer, this bankruptcy option represents a last-resort safety net if other avenues fail.
Bayer Faces Legal Setbacks and Mounting Financial Pressure
Legal defeats in multiple courtrooms have compounded Bayer’s Roundup crisis as the company faces overwhelming financial pressure. The pharmaceutical giant has lost three consecutive trials related to the allegedly carcinogenic effects of glyphosate, markedly increasing investor concerns about future liability.
Most recently, a Georgia jury ordered Bayer to pay nearly $2.1 billion in a Roundup lawsuit brought by a man who claimed that Roundup caused his cancer. Likewise, a Missouri appeals court upheld a $611 million judgment involving three plaintiffs who claimed their cancers resulted from Roundup exposure. These defeats follow another significant loss where Bayer was ordered to pay $332 million in damages to a California plaintiff.
Appeals to higher courts have repeatedly failed. The U.S. Supreme Court has already rejected two previous Bayer petitions seeking to block Roundup lawsuits. Yet another appeal awaits a decision, with parties given until June 9 to file arguments on whether the Court should accept the case.
What This Means for Roundup Users and Future Lawsuits
Bayer stands at a crossroads as it navigates the massive litigation challenge surrounding Roundup weed killer and its alleged link to cancer. The company has already paid billions of dollars to resolve these legal claims, yet it still faces thousands of pending lawsuits in state and federal courts across the country. As a result, the company now pursues two parallel strategies to protect itself from future liability for Roundup lawsuits.
Roundup Lawsuit Information
Court finds makers of Roundup legally liable for failing to warn of cancer on products, KOMU 8
Bayer ordered to pay $332 mln in Roundup cancer trial, Reuters
Roundup Lawsuits, Leading Justice


